Drug factory · FDA FEI 3002808159

Olon SpA

Via Livelli 1, Casaletto Lodigiano (Mairano), Italy

Italy: 1

Problems found, fixed voluntarily at FDA's last inspection, Jan 16, 2026.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

5 drug inspections on record since 2009: 2 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
CiclopiroxTests it Glenmark Pharmaceuticals Inc., USA 68462-297
KetotifenMakes the active ingredient Johnson & Johnson Vision Care, Inc. 60123-019

FDA inspection history

EndedResultProgramProblems noted
Jan 16, 2026Problems found, fixed voluntarilyDrug Quality Assurance—
Aug 2, 2019No problems foundDrug Quality Assurance—
Apr 30, 2015No problems foundDrug Quality Assurance—
Apr 5, 2012Problems found, fixed voluntarilyDrug Quality Assurance—
Mar 27, 2009Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: analysis; api manufacture.